Targeting chronic myeloid leukemia stem cells with the hypoxia-inducible factor inhibitor acriflavine.
about
Inhibition of the H3K9 methyltransferase G9A attenuates oncogenicity and activates the hypoxia signaling pathway.Severe hypoxia selects hematopoietic progenitors with stem cell potential from primary Myelodysplastic syndrome bone marrow cell cultures.Targeting the Extracellular Signal-Regulated Kinase 5 Pathway to Suppress Human Chronic Myeloid Leukemia Stem Cells
P2860
Targeting chronic myeloid leukemia stem cells with the hypoxia-inducible factor inhibitor acriflavine.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Targeting chronic myeloid leuk ...... factor inhibitor acriflavine.
@en
Targeting chronic myeloid leuk ...... factor inhibitor acriflavine.
@nl
type
label
Targeting chronic myeloid leuk ...... factor inhibitor acriflavine.
@en
Targeting chronic myeloid leuk ...... factor inhibitor acriflavine.
@nl
prefLabel
Targeting chronic myeloid leuk ...... factor inhibitor acriflavine.
@en
Targeting chronic myeloid leuk ...... factor inhibitor acriflavine.
@nl
P2093
P2860
P50
P921
P1433
P1476
Targeting chronic myeloid leuk ...... e factor inhibitor acriflavine
@en
P2093
Antonella Gozzini
Ignazia Tusa
Ngoc Ho DeSouza
Shaoguang Li
P2860
P304
P356
10.1182/BLOOD-2016-10-745588
P407
P577
2017-06-02T00:00:00Z